@alyssamax7's Wegovy claims need a closer look

What did @alyssamax7 actually say?

Nothing about GLP-1 medications. At all. The entire transcript is a loose, partially misremembered rendition of Don McLean's "American Pie" from 1971. Lines like "drove my Chevy to the levee but the levee was dry" and "this will be the day that I died" are song lyrics, not health claims. There is no medical content here to fact-check in the traditional sense.

The video was tagged with #wegovy, #glp1, and #weightloss, which is how it ended up in a health content review queue. But the gap between those hashtags and the actual audio content is total. Either the creator posted the wrong audio, used trending health hashtags to chase the algorithm, or this was some kind of creative bit that did not land with any discernible context. Whatever the reason, the content and the tags have nothing to do with each other.

Does the science back this up?

There is no claim to evaluate against the science. The video contains zero assertions about semaglutide, tirzepatide, weight loss mechanisms, GLP-1 receptor agonists, dosing, side effects, or any related topic. Applying clinical literature here would be absurd.

That said, since the hashtags pulled this into a GLP-1 review, it is worth noting what the actual evidence base looks like for the drugs being referenced in the tags. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed semaglutide 2.4 mg weekly produced mean body weight reduction of 14.9% over 68 weeks in adults without diabetes. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide at 15 mg produced up to 20.9% mean weight reduction. These are real, peer-reviewed findings. They are just completely irrelevant to a video about a 1971 folk rock song.

What did they get wrong (or right)?

The creator got the lyrics slightly wrong, which is not a health claim but is worth noting for accuracy's sake. The actual lyric is "the day the music died," not "the day, the music died." More notably, "this will be the day that I died" is a misquote of "this'll be the day that I die." These are minor errors in a song context, but pattern-of-accuracy matters in any content review.

On health claims: there are none to grade. Right or wrong does not apply. What is worth flagging is the hashtag strategy. Tagging unrelated content with #wegovy and #glp1 to capture search traffic is a form of platform manipulation that muddies health information ecosystems. When people search GLP-1 content looking for legitimate information about medication side effects, dosing timelines, or clinical outcomes, they do not benefit from finding American Pie karaoke. This is not a medical harm, but it is a content quality problem.

What should you actually know?

If you landed on this video expecting information about Wegovy or GLP-1 medications, you were misled by the tags, not the creator's words. Here is what actually matters if you are researching these drugs.

• Semaglutide (Wegovy) and tirzepatide (Zepbound) are FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
• These are not interchangeable with compounded versions. Compounded semaglutide and tirzepatide are not FDA-approved and have different purity, potency, and formulation standards.
• Common side effects include nausea, vomiting, diarrhea, and constipation, particularly during dose escalation. Wilding et al. (2021, NEJM) reported 74.2% of semaglutide patients experienced GI adverse events.
• No GLP-1 receptor agonist has been approved as a cure for any disease. Weight reduction and glycemic improvement are clinical outcomes, not cures.
• A telehealth provider or endocrinologist is the appropriate source for dosing decisions, not TikTok content, regardless of the hashtags attached to it.